Sanglifehrin A, a Novel Cyclophilin-Binding Compound Showing Immunosuppressive Activity with a New Mechanism of Action-Reference-Cited by-同舟云学术

Sanglifehrin A, a Novel Cyclophilin-Binding Compound Showing Immunosuppressive Activity with a New Mechanism of Action

Published:2001-06-15 Issue:12 Volume:166 Page:7165-7171
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Zenke Gerhard,Strittmatter Ulrike,Fuchs Serge,Quesniaux Valerie F. J.,Brinkmann Volker,Schuler Walter,Zurini Mauro,Enz Albert,Billich Andreas,Sanglier Jean-Jacques,Fehr Theo

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands

2. The mechanism of action of cyclosporin A and FK506

3. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction

4. Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of Action

5. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophilin inhibition as a strategy for the treatment of human disease;Frontiers in Pharmacology;2024-07-08

2. Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B;JCI Insight;2024-06-20

3. Inhibitors of Cyclophilin A: Current and Anticipated Pharmaceutical Agents for Inflammatory Diseases and Cancers;Molecules;2024-03-11

4. A journey into the regulatory secrets of the de novo purine nucleotide biosynthesis;Frontiers in Pharmacology;2024-02-20

5. Drug discovery and optimization based on the co-crystal structure of natural product with target;European Journal of Medicinal Chemistry;2024-02